Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response by Iris van 't Erve, PhD, Isabelle Blanchard, BS, Judy Y. Pagtama, MSN, Alison J. Holmes Tisch, MSN, Ash A. Alizadeh, MD, PhD, Kavitha Ramchandran, MD, Heather A. Wakelee, MD, Sukhmani K. Padda, MD, Maximilian Diehn, MD, PhD, Joel W. Neal, MD, PhD

Get full text